Archived: Atomoxetine (Strattera®)

Advice

Following a full submission

Atomoxetine (Strattera) is not recommended for use within NHS Scotland for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older or in adolescents. This advice concerns use in children and adolescents only and does not cover use in adults.

Atomoxetine is no more effective than a stimulant preparation against which it has been assessed. Tolerability was similar, though with some differences in the individual adverse events reported. Unlike the available stimulant preparations, it is not a Controlled Drug under the Misuse of Drugs regulations 2001 and there is evidence that it lacks abuse potential.